Keyphrases
Tumor
71%
Positron Emission Tomography
53%
Cancer Xenograft
37%
Nuclear Imaging
37%
18F-fluorodeoxyglucose (18F-FDG)
33%
Head-and-neck Cancer
31%
PET Imaging
30%
Tumor Uptake
30%
AE105
29%
Photothermal Cancer Therapy
29%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
29%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
29%
64Cu-ATSM
29%
Hypoxia
28%
Cyclooctatetraene
26%
FaDu
24%
Tumor Volume
23%
Nanoparticles
22%
Gene Expression
22%
Photothermal Therapy
22%
Nanomedicine
18%
F-18
18%
Early Treatment
18%
Tumor Tissue
18%
Targeted Agents
17%
Immunohistochemistry
17%
Cancer Treatment
17%
Autoradiography
16%
Targeted Imaging
16%
Radiosynthesis
16%
Diacetyl
16%
18F-FDG PET-CT
16%
Human Cancer
15%
Medicine and Dentistry
positron emission tomographic scan
100%
Neoplasm
98%
Polyethylene Terephthalate
53%
Copper 64
47%
Tumor Xenograft
39%
Radioactive Tracer
34%
Fluorodeoxyglucose F 18
34%
Molecular Imaging
31%
Urokinase Receptor
29%
Head and Neck Cancer
29%
Hypoxia
26%
Gene Expression
18%
Positron Emission Tomography-Computed Tomography
17%
Cancer Therapy
16%
Biological Marker
16%
